Two objects are being lifted by a machine. One object has a mass of 2 kg, and is lifted at a speed of 2 m/s. The other has a mass of 4 kg and is lifted at a rate of 3 m/s. A. Which object has more kinetic energy while it is being lifted?

B. What does this tell you about the variable(s) that impact kinetic energy?

C. Which object had more potential energy when it was lifted a distance of 10 m?

D. What does this tell you about the variable(s) that impact gravitational potential energy?

Water at room temperature of 20.0°c is poured into an aluminum cylinder which has graduation markings etched on the inside. the reading in the graduations is 300.0 cc. the cylinder with the water in it is then immersed in a constant temperature bath at a temperature of 100°c. what is the reading for the level of water on the graduations of the cylinder after the water and the cylinder reach thermal equilibrium with the bath? the volume coefficient of expansion of water is 2.07 x 10^-4 k-1, and the linear coefficient of expansion of aluminum is 23.0 x 10^-6 k-1. a) 305.0 cc b) 304.0 cc c) 303.5 cc d) 303.3 cc e) 304.5 cc

Which statement correctly describes the current in a circuit that is made up of any two resistors connected in parallel with a battery? a. the current in the battery and in each resistor is the same b. the current the battery equals to the sum of the currents in the resistors c. the current in the battery is less than the current in either resistor d. the current in the battery equals to the product of the currents in the resistors

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience. b. report the adverse drug experience to the irb only if there are several other occurrences. c. report the adverse drug experience as part of the continuing review report. d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.